The table below shows Dare Bioscience, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$5.52M
-$5.47M
-$6.81M
-$16.12M
-$12.34M
-$8.38M
Capital expenditure
$0.00
$157.33K
$7.30K
$0.00
$4.55K
$0.00
Investing cash flow
$0.00
-$157.33K
-$7.30K
$0.00
-$4.55K
$0.00
Dividends paid
-
-
-
-
DARE operating cash flow (10-K history)
Dare Bioscience, Inc. reported operating cash flow of -$9.89M for fiscal year 2025. That is down 280.6% from $5.47M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow declined from -$2.54M (FY 2017) to -$9.89M. Figures come from the company's audited annual reports as filed with the SEC.